NCT07367516 2026-03-04Clinical Trial Evaluating TQB6411 Injection in Subjects With Esophageal CancerChia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 1/2 Recruiting105 enrolled
NCT06047379 2026-03-02Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain MetastasisNeonc Technologies, Inc.Phase 1/2 Recruiting134 enrolled
NCT05438420 2026-02-24Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid TumorsQurient Co., Ltd.Phase 1/2 Active not recruiting120 enrolled
NCT04426669 2026-02-23A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic EngineeringIntima Bioscience, Inc.Phase 1/2 Completed23 enrolled